Skip to main content

Table 2 Toxicity observed in 79 Head and Neck cancer patients

From: Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs)

Late Toxicity

Grade 0

Grade 1

Grade 2

Grade 3

Cutaneous

26 (31.9%)

35 (44.3%)

17 (21.5%)

1 (1.3%)

Mucosa

44 (55.7%)

32 (40.5%)

2 (2.5%)

1 (1.3%)

Subcutaneous

33 (41.8%)

34 (43.0%)

11 (13.9%)

1 (1.3%)

Xerostomia

17 (21.6%)

28 (35.4%)

25 (31.6%)

9 (11.4%)

Larynx

54 (68.3%)

24 (30.4%)

1 (1.3%)

0 (0.0%)

Esophago

54 (68.3%)

18 (22.8%)

3 (3.8%)

4 (5.1%)